Timing of blood thinner shots in trauma patients
Part of Heart & circulation clinical trials.
This study looks at how the time of day you receive your blood thinner shot affects how well it works in preventing blood clots in the hospital. It may help doctors find the best time to give this medicine to trauma patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the hospital for treatment of a recent injury (at least 3 days since the injury).
- Your doctor has prescribed a daily blood thinner shot (called LMWH) to prevent blood clots.
- You are not pregnant.
- You do not have severe kidney or liver disease, or a bleeding disorder.
- You have not had a blood clot or been on blood thinners before this hospital stay.
- You do not have a brain bleed or an injury that is expected to be fatal.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the safest time to restart a blood thinner after a traumatic brain bleed. You will be placed in one of two groups: one that restarts the medicine early (about 1 week after the injury) and another that restarts it later (about 4 weeks after).
This study compares two doses of a blood thinner (enoxaparin) to see which better prevents blood clots in patients with severe injuries who are in the intensive care unit. It helps doctors choose the best dose to keep you safe and healthy.
This study looks at when it is safest to start blood thinners to prevent blood clots (deep vein thrombosis) after a type of bleeding stroke called hypertensive intracerebral hemorrhage. Researchers want to find the best time to start this prevention treatment.
This trial is testing the best time to start blood thinners (anticoagulation) after emergency stroke treatment in people who have atrial fibrillation. It is for patients who had a certain type of bleeding in the brain after the procedure.
This trial tests a drug called VMX-C001 to quickly reverse the effects of certain blood thinners (Factor Xa inhibitors) in people who need urgent surgery with a high risk of bleeding. It compares VMX-C001 to standard care to see which is more effective at helping blood clot normally.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
Hear when a new Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.